Artigos

Search for articles

BJO Oncology - Placeholder

Epidemiological surveillance of pancreatic cancer in the North region of the state of Rio Grande do Sul

ABSTRACT Introduction: Pancreatic neoplasia is considered a serious disease, associated with high mortality rates and late diagnosis. This pathology corresponds in the Brazilian scenario, about 2% of the diagnosed cancers. The main risk factors are: advanced age, male sex, black race, smoking, obesity, diabetes, pancreatitis, excessive alcohol use, as well as...
BJO Oncology - Placeholder

Complete laparoscopic resection of primary leiomyosarcoma of the lower vena cava

ABSTRACT The inferior vena cava leiomyosarcoma is a rare type of retroperitoneal sarcoma. Due to the small number of cases reported in literature, there is no well-defined protocol, based on randomized studies, on the most appropriate treatment for this neoplasia. Studies show that surgical resection R0 is the main curative...
BJO Oncology - Placeholder

Bullous pemphigoid associated with the use of nivolumab in a patient with metastatic melanoma: a case report.

ABSTRACT Benefits of immunotherapy within modern oncology are evident, especially when evaluating survival, morbidity and systemic effects in the treatment of neoplastic tumors. However, adverse events have been described in association with checkpoint inhibitors. We aim to describe a case of bullous pemphigoid in a patient with metastatic melanoma treated...
BJO Oncology - Placeholder

Primary lung cancer metastatic to the breast: case report of a patient in remission

ABSTRACT While lung carcinoma is the most common of the malignant tumors, primary lung tumors metastatic to the breast are rare and the prognosis is poor. We report a case of a Brazilian, 65- year-old, black, female patient with no family history of breast or lung cancer. During physical gynecological...
BJO Oncology - Placeholder

Epidermoid squamous cell carcinoma after pulmonary tuberculosis infection

ABSTRACT A 64-year-old female patient with uncompensated fever and secretive cough, an active smoker with a history of tuberculosis treated irregularly, developed non-small cell lung cancer such as squamous cell carcinoma in the pulmonary cavernoma.
BJO Oncology - Placeholder

Primary small cell carcinoma of the thyroid: a case report

ABSTRACT The diagnosis of cervical mass is a challenge due to the wide variety of benign and malignant etiologies. Extrapulmonary small cell carcinomas (EPSCC) are rare entities, and those tumours arising as a primary cervical, especially in the thyroid gland, are exceedingly rare. As others small cell neuroendocrine carcinomas, the...
BJO Oncology - Placeholder

Expression of EGFR family and p53 in a patient with Synchronous Primary Endometrial Adenocarcinoma and Clear Cell Renal Carcinoma: a Case Report

ABSTRACT We present a case of a 69 year-old, non-obese, post-menopausal woman diagnosed with synchronous endometrial adenocarcinoma and renal cell carcinoma. Immunolocalization and expression of the EGFR, HER-2, HER-3, HER-4 and p53 proteins by immunohistochemistry (IHC) was performed to investigate synchronous expression of these proteins. The endometrial adenocarcinoma was a...
BJO Oncology - Placeholder

Pulmonary Metastasis of a Prostate Adenocarcinoma within a Primary Lung Adenocarcinoma: A Tumor-totumor Metastasis Case Report

ABSTRACT Applications for68 Ga-PSMA PET-CT continue to expand beyond prostate cancer. The objective of this case report is to illustrate a rare phenomenon known as tumor-totumor metastasis in which precise histological diagnosis is an essential prerequisite for correct clinical management of patients. A 89-year-old man with prostate cancer underwent68 Ga-PSMA...
BJO Oncology - Placeholder

USE OF DENOSUMAB IN GIANT-CELL TUMOR AT A PUBLIC HOSPITAL IN SOUTHERN BRAZIL: REPORT OF 13 CASES

ABSTRACT Giant-cell tumor is a relatively rare neoplasia, benign but locally aggressive, that causes significant bone destruction with predilection for epiphyseal and metaphyseal regions of long bones and the spine. Definitive treatment is surgical, with complete tumoral resection followed by autograft, homograft, arthrodesis, unconventional endoprostheses or methylmethacrylate. In most cases,...
BJO Oncology - Placeholder

Metastatic castration-resistant prostate cancer (mCRPC) treated with 225Ac-PSMA-617. Case report

ABSTRACT Metastatic castration-resistant prostate cancer (mCRPC) is an extremely severe disease that relentlessly evolves to death. Over the past few years, we have seen significant improvements in the different types of treatments available, which have positively impacted several clinical outcomes, including higher survival rates and better quality of life. Since...